← SynDRA
Biib-068
SynDRA canonical compound SYN2381345 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | BTK |
|---|
| Mechanism of action | bruton's tyrosine kinase (btk) inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BTK INHIBITOR
- JAK2 INHIBITOR
- MAP3K19 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AAK1
- BMP2K
- CD69
- CDK7
- CDKL2
- RIOK1
- RIOK2
- SMUG1
- NEIL2
- NLK
- OGG1
- PIP5K1A
- RIOK3
- RPS6KA5
- STK16
- SRC
- MUTYH
- STK26
- TDG
- TEC
- TIE1
- TRIM24
- TYK2
- NEIL1
- MAPK1
- MBD4
- CYP2C19
- AURKA
- BRD4
- BRPF1
- CDK2
- CSNK1D
- CYP1A2
- CYP2B6
- CYP2C9
- ABL1
- CYP2D6
- CYP3A4
- FGFR3
- GSK3B
Cross-references
Synonyms
- BIIB068
- M6RN4LQ25S
- compound 1 [PMID: 32696648]
- compound 1 (PMID: 32696648)
- RefChem:119787
- UNII-M6RN4LQ25S
- orb1298296
- SCHEMBL16793996
- GTPL11178
- EX-A4364
- BDBM50553436
- AKOS040759716
- MS-27801
- DB-411143
- HY-131342
- CS-0133440
- T9192
- G17450
Look up Biib-068 in the interactive SynDRA portal →